Silicon Laboratories (SLAB)
(Delayed Data from NSDQ)
$122.13 USD
+3.20 (2.69%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $122.10 -0.03 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Silicon Laboratories, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -34.52 | 91.40 | 2,117.40 | 12.53 | 19.27 |
Depreciation/Amortization & Depletion | 52.04 | 58.60 | 85.32 | 83.95 | 69.95 |
Net Change from Assets/Liabilities | -100.30 | -47.60 | 20.68 | -18.38 | -0.54 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | -2,175.27 | 0.00 | 0.00 |
Other Operating Activities | 52.42 | 38.87 | 43.07 | 57.62 | 77.85 |
Net Cash From Operating Activities | -30.35 | 141.27 | 91.20 | 135.72 | 166.52 |
Property & Equipment | -22.28 | -26.53 | -28.58 | -20.42 | -16.28 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -316.81 | -2.51 |
Investments | 492.61 | 267.06 | -446.93 | -22.21 | -79.59 |
Other Investing Activities | -0.52 | 0.00 | -1.16 | -1.57 | -8.40 |
Net Cash from Investing Activities | 469.81 | 240.54 | -476.67 | -361.01 | -106.77 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -202.53 | -871.65 | -1,135.86 | -1.27 | -12.22 |
Issuance (Repayment) of Debt | -491.16 | -0.02 | -140.57 | 845.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -18.19 | -15.39 | -22.24 | -642.86 | -17.43 |
Net Cash from Financing Activities | -711.87 | -887.05 | -1,298.67 | 200.87 | -29.65 |
Effect of Exchange Rate Changes | 0.00 | -69.47 | 2,556.04 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -272.41 | -574.71 | 871.90 | -24.43 | 30.10 |
Cash at Beginning of Period | 499.92 | 1,074.62 | 202.72 | 227.15 | 197.04 |
Cash at End of Period | 227.50 | 499.92 | 1,074.62 | 202.72 | 227.15 |
Diluted Net EPS | -1.09 | 2.54 | 47.78 | 0.28 | 0.43 |
Fiscal Year End for Silicon Laboratories, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -34.52 | 35.27 | 24.92 | 13.97 |
Depreciation/Amortization & Depletion | NA | 52.04 | 39.11 | 26.31 | 13.27 |
Net Change from Assets/Liabilities | NA | -100.30 | -155.71 | -92.79 | -55.52 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 52.42 | 32.44 | 26.06 | 15.00 |
Net Cash From Operating Activities | NA | -30.35 | -48.89 | -15.50 | -13.28 |
Property & Equipment | NA | -22.28 | -18.53 | -13.46 | -7.66 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 492.61 | 445.35 | 429.82 | 261.94 |
Other Investing Activities | NA | -0.52 | -0.40 | -0.22 | 0.00 |
Net Cash from Investing Activities | NA | 469.81 | 426.42 | 416.14 | 254.28 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -202.53 | -209.12 | -193.31 | -17.61 |
Issuance (Repayment) of Debt | NA | -491.16 | -491.16 | -456.12 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -18.19 | -17.24 | -16.31 | -6.93 |
Net Cash from Financing Activities | NA | -711.87 | -717.52 | -665.74 | -24.54 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -272.41 | -339.99 | -265.10 | 216.46 |
Cash at Beginning of Period | NA | 499.92 | 499.92 | 499.92 | 499.92 |
Cash at End of Period | NA | 227.50 | 159.93 | 234.81 | 716.38 |
Diluted Net EPS | NA | -2.15 | 0.32 | 0.33 | 0.41 |